Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
JAMA
    October 2024
  1. GROSSMAN D, Kinsey ET
    Over-the-Counter Oral Contraceptives.
    JAMA. 2024 Oct 9. doi: 10.1001/jama.2024.16474.
    >> Share

    September 2024
  2. LYNCH HF, Lurie P, Cohen IG
    Checks and Balances on FDA's Authority.
    JAMA. 2024;332:705-706.
    >> Share

    August 2024
  3. GOODWIN MB, Whelan AM, Gostin LO
    Food and Drug Administration v Alliance for Hippocratic Medicine-A Cautious Win for Reproductive Health Care and FDA Authority.
    JAMA. 2024;332:453-454.
    >> Share

    July 2024
  4. QATO DM, Guadamuz JS, Myerson R
    Changes in Emergency Contraceptive Fills After Massachusetts' Statewide Standing Order.
    JAMA. 2024 Jul 2:e2411715. doi: 10.1001/jama.2024.11715.
    >> Share

    June 2024
  5. RALPH LJ, Baba CF, Biggs MA, McNicholas C, et al
    Comparison of No-Test Telehealth and In-Person Medication Abortion.
    JAMA. 2024 Jun 24:e2410680. doi: 10.1001/jama.2024.10680.
    >> Share

  6. HARRIS E
    Receiving Abortion Medication Through Mail Was Safe, Effective.
    JAMA. 2024 Jun 7. doi: 10.1001/jama.2024.10330.
    >> Share

    May 2024
  7. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
    The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    JAMA. 2024;331:1748-1760.
    >> Share

  8. ESPEY E, Hailstorks T, Hofler L
    Understanding the Impacts of the Supreme Court Case FDA v Alliance for Hippocratic Medicine.
    JAMA. 2024;331:1529-1530.
    >> Share

    April 2024
  9. HARRIS E
    Over-the-Counter Birth Control Pill Now Available in US.
    JAMA. 2024;331:1354.
    >> Share

  10. HARRIS E
    Use of Progestogen Tied to Higher Chance of Benign Brain Tumor.
    JAMA. 2024 Apr 19. doi: 10.1001/jama.2024.5923.
    >> Share

    March 2024
  11. FERNANDEZ LYNCH H, Kesselheim AS
    The FDA in the Crosshairs-Science, Politics, and Abortion.
    JAMA. 2024 Mar 25. doi: 10.1001/jama.2024.2229.
    >> Share

  12. AIKEN ARA, Wells ES, Gomperts R, Scott JG, et al
    Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision.
    JAMA. 2024 Mar 25:e244266. doi: 10.1001/jama.2024.4266.
    >> Share

    October 2023
  13. MEEGAN MA
    Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access.
    JAMA. 2023 Oct 26. doi: 10.1001/jama.2023.21591.
    >> Share

    September 2023
  14. HARRIS E
    Blot Clot Risk Higher When Pain Relievers Used With Hormonal Contraception.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17823.
    >> Share

  15. FLEURANT E, Mokashi M, Simon MA
    Over-the-Counter Progestin-Only Oral Contraceptives.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17781.
    >> Share

    August 2023
  16. HARRIS E
    FDA Greenlights First Over-the-Counter Oral Birth Control.
    JAMA. 2023;330:585.
    >> Share

    July 2023
  17. JUGL S, Winterstein AG
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
    JAMA. 2023;330:378.
    >> Share

  18. MEAIDI A, Torp-Pedersen C, Morch LS
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems-Reply.
    JAMA. 2023;330:378-379.
    >> Share

  19. BOOS EW, Horta M, Thompson I, Dusetzina SB, et al
    Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
    JAMA. 2023 Jul 21. doi: 10.1001/jama.2023.13628.
    >> Share

  20. BRANDI K, Upadhya KK, Teal SB
    Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity.
    JAMA. 2023 Jul 14. doi: 10.1001/jama.2023.10825.
    >> Share

    June 2023
  21. RUBIN R
    Over-the-Counter Birth Control Pill Could Be Available in the US by Year's End.
    JAMA. 2023;329:2009-2010.
    >> Share

  22. GLUCK AR
    The Mifepristone Case and the Legitimacy of the FDA.
    JAMA. 2023 Jun 2. doi: 10.1001/jama.2023.8712.
    >> Share

    April 2023
  23. AARON DG, Brown TR, Sinha MS
    Court Intrusion Into Science and Medicine-the Mifepristone Decisions.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.7790.
    >> Share

    March 2023
  24. MEAIDI A, Torp-Pedersen C, Lidegaard O, Morch LS, et al
    Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
    JAMA. 2023;329:935-937.
    >> Share

  25. AVERBACH S, Kully G, Hinz E, Dey A, et al
    Early vs Interval Postpartum Intrauterine Device Placement: A Randomized Clinical Trial.
    JAMA. 2023;329:910-917.
    >> Share

  26. HARRIS E
    On-Demand Male Contraceptive Compound Promising in Mouse Study.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2888.
    >> Share

    February 2023
  27. CRANDALL CJ, Mehta JM, Manson JE
    Management of Menopausal Symptoms: A Review.
    JAMA. 2023;329:405-420.
    >> Share

    December 2022
  28. ROLAND N, Baricault B, Weill A, Bouillon K, et al
    Association Between Doses of Levonorgestrel Intrauterine Systems and Subsequent Use of Psychotropic Drugs in France.
    JAMA. 2022 Dec 22. doi: 10.1001/jama.2022.21471.
    >> Share

    August 2022
  29. COHEN RH, Teal SB
    Medication Abortion.
    JAMA. 2022 Aug 19. pii: 2795652. doi: 10.1001/jama.2022.14805.
    >> Share

  30. STARK EL, Gariepy AM, Son M
    What Is Long-Acting Reversible Contraception?
    JAMA. 2022 Aug 12. pii: 2795467. doi: 10.1001/jama.2022.14239.
    >> Share

    July 2022
  31. SLOMSKI A
    Emergency Contraception Caution for Women With Obesity.
    JAMA. 2022;328:322.
    >> Share

  32. LINDLEY KJ, Teal SB
    Contraception in Women With Cardiovascular Disease.
    JAMA. 2022 Jul 22. pii: 2794754. doi: 10.1001/jama.2022.11541.
    >> Share

    June 2022
  33. COHEN RH, Teal SB
    Medication for Early Pregnancy Termination.
    JAMA. 2022 Jun 2. pii: 2793170. doi: 10.1001/jama.2022.6344.
    >> Share

    May 2022
  34. AVERBACH S, Hofler L
    Long-Acting Reversible Contraception With Contraceptive Implants and Intrauterine Devices.
    JAMA. 2022 May 6. pii: 2792212. doi: 10.1001/jama.2022.5448.
    >> Share

    April 2022
  35. SKARITANOV E, Wilkie G, Kovell LC
    Selection, Effectiveness, and Adverse Effects of Contraception.
    JAMA. 2022;327:1504.
    >> Share

  36. TEAL S, Edelman A
    Selection, Effectiveness, and Adverse Effects of Contraception-Reply.
    JAMA. 2022;327:1505.
    >> Share

    January 2022
  37. HUDDLESTON HG, Dokras A
    Diagnosis and Treatment of Polycystic Ovary Syndrome.
    JAMA. 2022;327:274-275.
    >> Share

  38. SPECTOR LG, Moertel CL, Su HI
    Maternal Contraceptive Use and Central Nervous System Tumors in Offspring.
    JAMA. 2022;327:39-40.
    >> Share

  39. HARGREAVE M, Morch LS, Winther JF, Schmiegelow K, et al
    Association Between Maternal Hormonal Contraception Use and Central Nervous System Tumors in Children.
    JAMA. 2022;327:59-66.
    >> Share

    December 2021
  40. TEAL S, Edelman A
    Contraception Selection, Effectiveness, and Adverse Effects: A Review.
    JAMA. 2021;326:2507-2518.
    >> Share

  41. RUBIN R
    Expanding Access to Medication Abortions.
    JAMA. 2021 Dec 22. pii: 2787610. doi: 10.1001/jama.2021.23357.
    >> Share

    November 2021
  42. EICHENFIELD DZ, Sprague J, Eichenfield LF
    Management of Acne Vulgaris: A Review.
    JAMA. 2021;326:2055-2067.
    >> Share

  43. PITTS S, DiVasta AD, Gordon CM
    Evaluation and Management of Amenorrhea.
    JAMA. 2021;326:1962-1963.
    >> Share

  44. BALKUS JE, Dionne-Odom J, Wiesenfeld HC
    Contraception Requirements in Clinical Trials: Considerations From Studies on Sexually Transmitted Infections.
    JAMA. 2021 Nov 3. pii: 2786022. doi: 10.1001/jama.2021.19473.
    >> Share

    October 2021
  45. KAUNITZ AM, Kapoor E, Faubion S
    Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause.
    JAMA. 2021;326:1429-1430.
    >> Share

    August 2021

  46. Phexxi-A Nonhormonal Contraceptive Gel.
    JAMA. 2021;326:763-764.
    >> Share

    July 2021
  47. KUEHN BM
    CDC Recommends Self-injected Contraceptive Option.
    JAMA. 2021;326:125.
    >> Share

    December 2019
  48. KHO KA, Shields JK
    Diagnosis and Management of Primary Dysmenorrhea.
    JAMA. 2019 Dec 19. pii: 2758078. doi: 10.1001/jama.2019.16921.
    >> Share

  49. DOUGLASS LA, Davis AM
    Assessment and Management of Heavy Menstrual Bleeding.
    JAMA. 2019 Dec 19. pii: 2758077. doi: 10.1001/jama.2019.17383.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016